Journal article
Authors list: Maurer, Marcus; Schuetz, Andrea; Weller, Karsten; Schoepke, Nicole; Peveling-Oberhag, Adriane; Staubach, Petra; Mueller, Sabine; Jakob, Thilo; Metz, Martin
Publication year: 2017
Pages: 870-87+
Journal: Journal of Allergy and Clinical Immunology
Volume number: 140
Issue number: 3
ISSN: 0091-6749
eISSN: 1097-6825
Open access status: Bronze
DOI Link: https://doi.org/10.1016/j.jaci.2017.01.042
Publisher: Elsevier
Citation Styles
Harvard Citation style: Maurer, M., Schuetz, A., Weller, K., Schoepke, N., Peveling-Oberhag, A., Staubach, P., et al. (2017) Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial, Journal of Allergy and Clinical Immunology, 140(3), pp. 870-87+. https://doi.org/10.1016/j.jaci.2017.01.042
APA Citation style: Maurer, M., Schuetz, A., Weller, K., Schoepke, N., Peveling-Oberhag, A., Staubach, P., Mueller, S., Jakob, T., & Metz, M. (2017). Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. Journal of Allergy and Clinical Immunology. 140(3), 870-87+. https://doi.org/10.1016/j.jaci.2017.01.042
Keywords
urticaria
